Dual Therapy

(4:49)

Heart Minute | Dual Antiplatelet Therapy after Ischemic Stroke or TIA

(1:22)

The Changing Face of Dual Anti-Platelet Therapy: Implications for the Internist

(30:7)

Dual Versus Triple Therapy In Patients Undergoing Stent Implantation Who Are On Anticoagulation

(6:59)

Rationale for Dual Therapy with Therapies Targeting CGRP Signaling | Prof. Dodick | ICAMS 2022

(29:17)

Patient Education: Dual antiplatelet therapy (DAPT) after heart attack or stent

(6:25)

Dual Antiretroviral Therapy (ART): What Do We Know?

(18:52)

Predicting response and survival in patients with PTCL treated with pembrolizumab and romidepsin

(1:46)

Challenges of dual-targeted CAR T-cell therapy

(1:13)

Dual Antiplatelet Therapy: Whiteboard Animation

(5:27)

Mastering the Use of Dual Antiplatelet Therapy for Preventing Recurrent Stroke

(1:26:30)

Dual Therapy with Dolutegravir and Lamivudine | Pedro Cahn, MD, PhD (Original)

(22:7)

Dual Therapy Machine

(7:1econd)

Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial

(2:5)

How long to give dual antiplatelet therapy (DAT) in acute MI? | Dr Viveka Kumar | Medtalks

(1:7)

MASTER DAPT trial: Dual antiplatelet therapy after coronary stenting - AICT-AsiaPCR 2021

(52:11)

Expedited recommendation for short-term dual antiplatelet therapy after minor stroke \u0026 high-risk TIA

(1:48)

Dual therapy drug trial offers hope to HIV patients

(11:44)

ARAMIS: dual antiplatelet therapy non-inferior to alteplase in minor ischemic stroke

(4:46)

Controversy: Dual vs Triple antithrombotic therapy in AF patients undergoing PCI. What’s best?

(54:24)